仁度生物跌7.62% 2022年上市即巅峰募7.3亿

Group 1 - Rendu Biotech's stock price fell by 7.62% to 52.15 yuan, with a total market value of 2.09 billion yuan, currently in a state of breaking issue [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 30, 2022, with an initial offering price of 72.65 yuan per share [1] - Rendu Biotech raised a total of 726.5 million yuan, with a net amount of 652.76 million yuan after deducting issuance costs, which was 47.75 million yuan less than originally planned [1] Group 2 - The controlling shareholder and actual controller of Rendu Biotech is Ju Jinliang, who has held various positions in notable companies and has been the chairman and chief scientist since 2007 [2]